140 related articles for article (PubMed ID: 36529681)
1. Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.
Lam L; Fontaine H; Lapidus N; Bellet J; Lusivika-Nzinga C; Nicol J; Dorival C; Cagnot C; Hejblum G; Pol S; Bourlière M; Carrat F;
J Viral Hepat; 2023 Mar; 30(3):232-241. PubMed ID: 36529681
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
Hwang JP; Arnold KB; Unger JM; Chugh R; Tincopa MA; Loomba R; Hershman D; Ramsey SD
Support Care Cancer; 2022 Dec; 31(1):93. PubMed ID: 36585488
[TBL] [Abstract][Full Text] [Related]
3. Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.
Niu B; Forde KA; Goldberg DS
Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):107-11. PubMed ID: 25335773
[TBL] [Abstract][Full Text] [Related]
4. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.
Zhou K; Terrault NA
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):188-195.e4. PubMed ID: 31173892
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and current management of hepatitis B and C in China.
Sun YT; Zhang YX; Tang H; Mao Q; Wang XZ; Zhang LY; Chen H; Zhong YN; Lin SM; Zhang DZ
World J Gastroenterol; 2014 Oct; 20(37):13582-90. PubMed ID: 25309089
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.
Ramsey SD; Unger JM; Baker LH; Little RF; Loomba R; Hwang JP; Chugh R; Konerman MA; Arnold K; Menter AR; Thomas E; Michels RM; Jorgensen CW; Burton GV; Bhadkamkar NA; Hershman DL
JAMA Oncol; 2019 Apr; 5(4):497-505. PubMed ID: 30653226
[TBL] [Abstract][Full Text] [Related]
7. Validity of ICD-10-CM Codes Used to Identify Patients with Chronic Hepatitis B and C Virus Infection in Administrative Claims Data from the Taiwan National Health Insurance Outpatient Claims Dataset.
Sheu MJ; Liang FW; Li ST; Li CY; Lu TH
Clin Epidemiol; 2020; 12():185-192. PubMed ID: 32110110
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Yeh ML; Hung CH; Tseng KC; Lai HC; Chen CY; Kuo HT; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Huang CF; Huang JF; Dai CY; Chuang WL; Tsai PC; Peng CY; Liu CJ; Yu ML
Hepatol Int; 2021 Oct; 15(5):1109-1121. PubMed ID: 34365587
[TBL] [Abstract][Full Text] [Related]
9. Validation of coding algorithms for identifying people with viral hepatitis using claims data according to different standard references.
Sheu MJ; Chin TW; Ku FP; Li CY; Li ST; Lu TH
BMC Infect Dis; 2022 Mar; 22(1):222. PubMed ID: 35246067
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.
Megna M; Patruno C; Bongiorno MR; Gambardella A; Guarneri C; Romita P; Raimondo A; Loconsole F; Fabbrocini G
Clin Drug Investig; 2022 Jun; 42(6):525-531. PubMed ID: 35633470
[TBL] [Abstract][Full Text] [Related]
11. Care quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct-acting antiviral era.
Kaplan DE; Medvedeva E; Serper M
J Viral Hepat; 2020 Oct; 27(10):1082-1092. PubMed ID: 32484991
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
De Vroey B; Moreno C; Laleman W; van Gossum M; Colle I; de Galocsy C; Langlet P; Robaeys G; Orlent H; Michielsen P; Delwaide J; Reynaert H; D'Heygere F; Sprengers D; Bourgeois S; Assene C; Vos B; Brenard R; Adler M; Henrion J; Deltenre P
Eur J Gastroenterol Hepatol; 2013 May; 25(5):613-9. PubMed ID: 23325285
[TBL] [Abstract][Full Text] [Related]
13. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
[TBL] [Abstract][Full Text] [Related]
14. Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.
Pol S;
Aliment Pharmacol Ther; 2021 Mar; 53(5):616-629. PubMed ID: 33464621
[TBL] [Abstract][Full Text] [Related]
15. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
Bonifati C; Lora V; Graceffa D; Nosotti L
World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
[TBL] [Abstract][Full Text] [Related]
16. Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Santos M; Protopopescu C; Delarocque-Astagneau E; Bourlière M; Petrov-Sanchez V; Di Beo V; Larrey D; Baudoin M; Dorival C; Bureau M; Fontaine H; Carrat F; Marcellin F; Pol S; Carrieri P;
Liver Int; 2022 Jan; 42(1):38-49. PubMed ID: 34520614
[TBL] [Abstract][Full Text] [Related]
17. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.
Pol S; Haour G; Fontaine H; Dorival C; Petrov-Sanchez V; Bourliere M; Capeau J; Carrieri P; Larrey D; Larsen C; Marcellin P; Pawlostky JM; Nahon P; Zoulim F; Cacoub P; de Ledinghen V; Mathurin P; Negro F; Pageaux GP; Yazdanpanah Y; Wittkop L; Zarski JP; Carrat F;
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1054-1060. PubMed ID: 28994127
[TBL] [Abstract][Full Text] [Related]
18. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Lam L; Fontaine H; Bourliere M; Lusivika-Nzinga C; Dorival C; Thabut D; Zoulim F; Habersetzer F; Asselah T; Duclos-Vallee JC; Bronowicki JP; Mathurin P; Decaens T; Ganne N; Guyader D; Leroy V; Rosa I; De Ledinghen V; Cales P; Causse X; Larrey D; Chazouilleres O; Gelu-Simeon M; Loustaud-Ratti V; Metivier S; Alric L; Riachi G; Gournay J; Minello A; Tran A; Geist C; Abergel A; Raffi F; D'Alteroche L; Portal I; Lapidus N; Pol S; Carrat F;
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101713. PubMed ID: 33930591
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
Nguyen LH; Ko S; Wong SS; Tran PS; Trinh HN; Garcia RT; Ahmed A; Lutchman GA; Keeffe EB; Nguyen MH
Hepatology; 2011 Jun; 53(6):1839-45. PubMed ID: 21425314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
